New Low Float Idea (Nasdaq: CABR) Takes Control Of Wednesday's Watchlist (5 Potential Catalysts)

In a world where compassion and commerce rarely intersect

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored New Low Float Idea (Nasdaq: CABR) Takes Control Of Wednesday's Watchlist (5 Potential Catalysts) *Get Our Updates Faster—Tap Here To Receive SMS Alerts* January 20th Greetings, Friend! In a world where compassion and commerce rarely intersect, one company is proving they can. Operating quietly but making a meaningful impact, this company blends genuine care with smart strategy to meet the growing demand for products that nurture well-being. With a focus on quality, trust, and innovation that resonates beyond the marketplace, this enterprise continues to expand its reach and reputation. It’s the kind of company that doesn’t just move with trends—it helps set the standard for what thoughtful success looks like. And with a low float of fewer than 5Mn shares and a recent uplisting that could generate added visibility, this under-the-radar Nasdaq idea hits our radar: Caring Brands, Inc. (Nasdaq: CABR) Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends to launch a total of 5 products over the next 2 years in addition to in-licensing additional products. Management has a successful track record of strategic acquisitions, rapid product development, IP development and product licensing. Caring Brands' Science -Clinical Research Caring Brands Inc. believes in building an evidence-based foundation through clinical studies and research and is dedicated to ensuring the reliability and efficacy of its products. As part of this commitment, the company is in-vest-ing in rigorous research and development to ensure that its products meet the highest standards. The company’s trials are designed to examine the safety, efficacy, and potential benefits of all its innovative products. Caring Brands Inc. currently has a multi-stage trial underway to validate the benefits of JW-700 (minoxidil booster). In addition, several other trials are in the planning stages for the company’s latest product candidates. Caring Brands Inc. remains confident that its commitment to evidence-based results will lead to products that exceed customer expectations and provide the highest quality of care. Science-Backed Value Creation Philosophy Products With Purpose Caring Brands support heal-th and wellness through the research and development of over-the-counter (OTC) products and intellectual property. Their product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Revenue is generated through the sales of OTC and consumer products and licensing royalties. Hair Loss Product - Topical treatment designed to improve minoxidil efficacy. Studies - Clinically shown to increase the enzymes needed for minoxidil to work, sulfotransferase enzymes, by up to 7x over a two-week period. Sales Channels - Licensed to Taisho, a $2.6Bn revenue company and Japan’s leading seller of minoxidil products, with their commercial launch planned for 2023. Licensed to India-based Cosmofix Technovation Pvt Ltd and Sanpellegrino Cosmetics with product launch planning underway. Next Steps - Additional licensing opp's are being pursued abroad. Psoriasis and Vitiligo Product - Topical treatment for psoriasis and vitiligo. Studies - Photocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. Sales Channels - Photocil became commercially available in the United States in Q4 2022 as an FDA-approved OTC product under a USP monograph for psoriasis and vitiligo. Next Steps - The scientific formulation is finished, and clinical research is currently in progress. Eczema Product - Topical treatment of atopic dermatitis (eczema). Studies - JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. A Phase 3, double-blind, placebo-controlled multi-center trial is underway to evaluate the superiority of JW-100 to Eucrisa (an FDA-approved topical drug) in mild-to-moderate eczema. Sales Channels - JW-100 is pre-revenue. Jellyfish Protection Sunscreen Product - Topical protection from jellyfish, sea lice, and UVA/UVB rays. Studies - NoStingz provides an effective barrier against the stinging mechanism of jellyfish cnidocyte preventing the delivery of venom to the victim. Sales Channels - NoStingz has been available online through Amazon and Walmart as well as in select stores starting in April-June 2022. Next Steps - A plan is in place to expand our B2B store counts and shelf space as well as optimize the product offerings to drive greater online sales. Read More And Grab Sources: CABR Website. ----- 5 Potential Catalysts We're Currently Tracking - (Nasdaq: CABR) 1.) A Small Float Of This Size Could Create A Situation For Significant Volatility Potential. With roughly 4.14Mn shares in its float, volatility potential could become heightened at the drop of a hat for CABR. 2.) Caring Brands Expands Global Reach With Exclusive Emesyl Licensing Deal. Caring Brands Inc. secured exclusive global rights from Itonis Inc. to manufacture, market, and distribute Emesyl, a leading over-the-counter nausea relief product. This agreement gives Caring Brands full control over production, marketing, and worldwide sales while gaining access to Itonis’s technical expertise and intellectual property. Company CEO Glynn Wilson called the deal a major milestone in expanding Caring Brands’ health and wellness portfolio. With the $6.23Bn nausea treatment market growing, Caring Brands is well positioned for strong international expansion and future revenue growth. 3.) Caring Brands Gains Visibility Through Successful Nasdaq Uplisting. Caring Brands Inc. completed a $4Mn underwritten public offering, marking its official uplisting to the Nasdaq Capital Market under the ticker “CABR.” This milestone uplisting increases Caring Brands’ visibility among institutional and retail market watchers, broadens market access, and supports its strategy to accelerate growth in the wellness and over-the-counter consumer products sector. The achievement underscores growing momentum and solid financial positioning for future expansion. 4.) Potential Healthy Reversal Could Be Nearing For CABR. Technical analysis reveals CABR has several oversold indicators, suggesting a possible reversal setup may be developing. At close on Tuesday, CABR had a 9-Day and 14-Day Relative Strength Index both below 35% and a 14-Day Raw Stochastic below 11%. These technical levels suggest a profile that may be currently undervalued. 5.) An Experienced Management Team Leads The Way. Dr. Glynn Wilson | Chief Executive Officer Dr. Glynn Wilson, a veteran biotech leader, previously served as CEO of TapImmune and held senior roles at SmithKline Beecham, Ciba-Geigy, and Access Pharmaceuticals. With a strong scientific background from Rockefeller University, he excels at translating innovation into commercial success. His leadership blends science and strategy, driving Caring Brands’ growth and innovation-focused mission. Brian John | Executive Chairman Brian John, founder of Caro Partners, has over 20 years of experience guiding emerging growth companies and launching successful Nasdaq-listed ventures like Jupiter Wellness and SRM Entertainment. A proven entrepreneur and investor, he brings deep financial insight, strategic acumen, and global business expertise to Caring Brands, strengthening its growth, visibility, and long-term shareholder value. Tyler Moore | Chief Financial Officer Tyler Moore has 20+ years of finance experience with Ernst & Young, Deloitte, Benefytt, and Waldencast. Skilled in SEC reporting, acquisitions, and financial strategy, he’s led major transactions and compliance efforts in wellness and tech sectors. His expertise ensures strong fiscal integrity, operational discipline, and scalable financial growth for Caring Brands’ expanding global operations. ----- Coverage is now officially underway on Caring Brands, Inc. (Nasdaq: CABR). Be on the lookout for updates coming your way soon. All the best, Dane James Editor Market Pulse Today (Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.) *MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 01/20/2026 and ending on 01/21/2026 to publicly disseminate information about (CABR:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid eight thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (CABR:US). Please see important disclosure information here: https://marketpulsetoday.com/disclosure/cabr-pvydi/#details

Market Pulse Today | 1314 E LAS OLAS BLVD UNIT #2170 | FORT LAUDERDALE, FL 33301 US Unsubscribe | Update Profile | Our Privacy Policy | Constant Contact Data Notice